section name header

Y-Site Injection Compatibility (1:1 Mixture)

Vancomycin HCl

(Mfr: BA)(Conc: 5 mg/mLb)

QMark

Lacosamide

(Mfr: UCB)(Conc: 10 mg/mL)

Remarks:

Inconsistent results from subvisible particle analyses. Microparticulates detected by 2 of 3 methods in 4 hr at 20 to 22°Chh

Ref:

3976